KEYSTONE 2015
Recent articles
Repurposed drugs may treat Angelman syndrome
An acne drug, a dietary supplement and a failed sleeping aid each show promise for Angelman syndrome, according to unpublished results presented Tuesday at a meeting.
Repurposed drugs may treat Angelman syndrome
An acne drug, a dietary supplement and a failed sleeping aid each show promise for Angelman syndrome, according to unpublished results presented Tuesday at a meeting.
Explore more from The Transmitter
Frameshift: How Caitlin Vander Weele made science communication her business
Her favorite part of research was talking about it. So she left academia and turned that passion into a successful company.
Frameshift: How Caitlin Vander Weele made science communication her business
Her favorite part of research was talking about it. So she left academia and turned that passion into a successful company.
Signs of aging vary across brain cells
Senescence presents differently depending on the cell type, toxic trigger and neighboring cells, two new studies find.
Signs of aging vary across brain cells
Senescence presents differently depending on the cell type, toxic trigger and neighboring cells, two new studies find.
Neuroscientists challenge NIH’s proposed human-data access policy
The changes would restrict the sharing of human neuroimaging, transcriptomic and genetic data.
Neuroscientists challenge NIH’s proposed human-data access policy
The changes would restrict the sharing of human neuroimaging, transcriptomic and genetic data.